Evidence map›Paper›PMID 24048858›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination.

Roberta Noseda, Sophie Belin, Françoise Piguet, Ilaria Vaccari, Stefania Scarlino, Paola Brambilla, Filippo Martinelli Boneschi, Maria Laura Feltri, Lawrence Wrabetz, Angelo Quattrini and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Schwann Cell Development and Myelination.Cold Spring Harbor perspectives in biology · 2024
    Review
  5. Molecular Characterization of Nodose Ganglia Development Reveals a Novel Population of Phox2b+ Glial Progenitors in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. ISCA1 is essential for mitochondrial FeNature communications · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Roberta NosedaDulbecco Telethon Institute at Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, 20132 Milan, Italy, UniSR, Vita Salute San Raffaele University, 20132 Milan, Italy, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, 20132 Milan, Italy, Hunter James Kelly Research Institute, University at Buffalo, State University of New York, Buffalo, New York 14203, Quark Pharmaceuticals, 70400 Ness Ziona, Israel, and The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Sophie Belin
Françoise Piguet
Ilaria Vaccari
Stefania Scarlino
Paola Brambilla
Filippo Martinelli Boneschi
Maria Laura Feltri
Lawrence Wrabetz
Angelo Quattrini
Elena Feinstein
Richard L Huganir
Alessandra Bolino
Dulbecco Telethon Institute · ITUniversity at Buffalo, State University of New York · USJohns Hopkins University · USQuark Pharmaceuticals (United States) · USSan Raffaele University of Rome · ITVita-Salute San Raffaele University · IT

Funding

PDZ DOMAINS AND EXCITATORY SYNAPTIC FUNCTIONR01NS036715 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1997 to 2020
$8.6M
Laminin Receptors and Signals in Schwann CellsR01NS045630 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SIM, FRASER JAMES · 2003 to 2024
$5.9M
NINDS NIH HHS R01 NS036715NINDS NIH HHS R01 NS045630Telethon GGP12017
6 · The paper itself

Abstract

Signals that promote myelination must be tightly modulated to adjust myelin thickness to the axonal diameter. In the peripheral nervous system, axonal neuregulin 1 type III promotes myelination by activating erbB2/B3 receptors and the PI3K/AKT/mTOR pathway in Schwann cells. Conversely, PTEN (phosphatase and tensin homolog on chromosome 10) dephosphorylates PtdIns(3,4,5)P3 and negatively regulates the AKT pathway and myelination. Recently, the DLG1/SAP97 scaffolding protein was described to interact with PTEN to enhance PIP3 dephosphorylation. Here we now report that nerves from mice with conditional inactivation of Dlg1 in Schwann cells display only a transient increase in myelin thickness during development, suggesting that DLG1 is a transient negative regulator of myelination. Instead, we identified DDIT4/RTP801/REDD1 as a sustained negative modulator of myelination. We show that DDIT4 is expressed in Schwann cells and its maximum expression level precedes the peak of AKT activation and of DLG1 activity in peripheral nerves. Moreover, loss of DDIT4 expression both in vitro and in vivo in Ddit4-null mice provokes sustained hypermyelination and enhanced mTORC1 activation, thus suggesting that this molecule is a novel negative regulator of PNS myelination.

Indexed as

Age FactorsAnimalsAnimals, NewbornCells, CulturedCoculture TechniquesDiscs Large Homolog 1 ProteinEmbryo, MammalianGanglia, SpinalGene Expression ProfilingGene Expression RegulationMiceMice, Inbred C57BLMice, KnockoutMutationMyelin Basic ProteinMyelin P0 ProteinDdit4 protein, mouseDiscs Large Homolog 1 ProteinDlg1 protein, mouseMbp protein, mouseMyelin Basic ProteinMyelin P0 ProteinNerve Tissue Proteinsneurofilament protein LNeurofilament ProteinsRNA, MessengerRNA, Small InterferingSAP90-PSD95 Associated ProteinsTranscription Factors

Identifiers

PMID24048858
PMCPMC3988321
OpenAlexW2063851696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.